This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, ...
CG Oncology Inc (CGON) stock saw a decline, ending the day at $28.76 which represents a decrease of $-0.11 or -0.38% from the prior close of $28.87. The stock opened at $29.2 and touched a low of $27.
This company paid for expanded information and features ... Read More Schedule an introduction with CG Modern Architecture today.
While the company has put a huge emphasis on targeting bladder cancer patients, the beauty of this oncolytic immunotherapy ...
CG Oncology shares are trading lower by 9.2% during Wednesday's session. The company announced it filed an underwritten ...
Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, TD Cowen and Stifel, Nicolaus & Company, Incorporated are acting as joint book-running managers for the offering. LifeSci Capital LLC is acting as ...
CG Oncology (NASDAQ:CGON – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a ...
Carlyle Group Inc (CG) stock saw a modest uptick, ending the day at $52.85 which represents a slight increase of $0.09 or 0.17% from the prior close of $52.76. The stock opened at $52.88 and touched a ...
MetLife Investment Management LLC increased its holdings in shares of CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 103.2% ...